BioSpace News Archive

New study sheds light on medication administration errors leading to death – omission is a common cause

Medication administration errors leading to death are common with anticoagulants and antibiotics in particular, according to a new study that analysed incidents reported in England and Wales.

December 7, 2018
·
3 min read
Gene-editing a significant leap forward in biomedical research but needs strong legal framework for ethical usage, says GlobalData

Following the recent claims by He Jiankui, a scientist and professor of Biology at the Southern University of Science and Technology in Shenzhen, Guangdong, China, that he has successfully created the world’s first gene-edited babies,

December 7, 2018
·
1 min read
Business

DOMAIN THERAPEUTICS SIGNS A MULTI-TARGET RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH BOEHRINGER INGELHEIM

Domain Therapeutics’ unique platform technologies will be used to identify novel treatment approaches for neuropsychiatric diseases

December 7, 2018
·
3 min read
Policy

Ministry of Health & Prevention meets with Chinese delegates to discuss AI and Chronic Diseases

he Ministry of Health and Prevention recently met with a Chinese delegation to discuss mutually beneficial cooperation in the use of technological innovations such as artificial intelligence (AI) in the health care sector.

December 7, 2018
·
1 min read
Policy

Syngenta exercises licensing option for enabling technology from Ingenza

Ingenza is pleased to announce that Syngenta is exercising its commercial licensing option for a technology that enables the development of innovative crop protection products.

December 7, 2018
·
2 min read
Business

iDD biotech receives second milestone payment from Genmab with enrollment of fifth patient in GEN1029 (HexaBody®-DR5/DR5) safety trial in patients with malignant solid tumors

iDD biotech reports that it has received a second milestone payment after its partner, Genmab, started a Phase I/IIa trial of GEN1029 (HexaBody-DR5/DR5).

December 7, 2018
·
2 min read
Deals

TESARO, Inc. Gives Notice of Anticipated Make-Whole Adjustment Event to Holders of Its Convertible Senior Notes

TESARO, Inc. today announced that, pursuant to the terms of the indenture (the “Indenture”) governing the terms of its 3.00% Convertible Senior notes due 2021

December 7, 2018
·
6 min read
Policy

Medtronic Announces Worldwide Voluntary Field Corrective Action; Company Issues Software Update for Puritan Bennett(TM) 980 (PB980) Ventilator Series

Medtronic is notifying customers worldwide of a voluntary field corrective action for its Puritan Bennett(TM) 980 (PB980) ventilator series. Medtronic initiated this field action on September 19, 2018.

December 7, 2018
·
2 min read
Drug Development

ADC Therapeutics Presents Updated Data from Clinical Trials of Novel Antibody Drug Conjugates

ADCT-402 (loncastuximab tesirine) continues to demonstrate acceptable safety profile and anti-tumor activity in patients with relapsed or refractory diffuse large B-cell lymphoma; data from 183-patient study supports continued evaluation in ongoing pivotal Phase II trial

December 7, 2018
·
8 min read
Business

Metafora biosystems appoints Christophe Béesau as chief scientific officer and chief technical officer

An expert in the application of artificial intelligence in precision medicine, Christophe Béesau’s appointment will allow Metafora to step up its efforts in oncology and immunology

December 7, 2018
·
3 min read